Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein
- 1 March 2001
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 76 (1-5) , 49-59
- https://doi.org/10.1016/s0960-0760(00)00145-x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- 1α,25(OH)2Vitamin D3-Regulated Expression of the Eukaryotic GenomeNutrition Reviews, 2009
- 1α,25‐Dihydroxyvitamin D3‐26,23‐lactone analogs antagonize differentiation of human leukemia cells (HL‐60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells)FEBS Letters, 1999
- Vitamin D Analogs, 20-Epi-22-Oxa-24a,26a,27a,-Trihomo-1 ,25(OH)2-Vitamin D3, 1,24(OH)2-22-Ene-24-Cyclopropyl-Vitamin D3 and 1 ,25(OH)2-Lumisterol3 Prime NB4 Leukemia Cells for Monocytic Differentiation via Nongenomic Signaling Pathways, Involving Calcium and CalpainEndocrinology, 1999
- Physiological Importance of the 1,25(OH)2D3 Membrane Receptor and Evidence for a Membrane Receptor Specific for 24,25(OH)2D3Journal of Bone and Mineral Research, 1999
- Receptors for 1α,25(OH)2D3: Past, Present, and FutureJournal of Bone and Mineral Research, 1998
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- Differential Interaction of α,25-Dihydroxyvitamin D3 Analogues and Their 20-epi Homologues with the Vitamin D ReceptorPublished by Elsevier ,1997
- Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acidNature, 1995
- A dialogue on analogues Newer vitamin-D drugs for use in bone disease, psoriasis, and cancerTrends in Endocrinology & Metabolism, 1993
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.The Journal of cell biology, 1984